 | • レポートコード：MRC2-11QY11183 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、94ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療機器・消耗品 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は脳腫瘍診断・治療のグローバル市場について調査・分析したレポートです。種類別（原発性脳腫瘍、続発性脳腫瘍）市場規模、用途別（病院、医療センター）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別脳腫瘍診断・治療の競争状況、市場シェア ・世界の脳腫瘍診断・治療市場：種類別市場規模 2015年-2020年（原発性脳腫瘍、続発性脳腫瘍） ・世界の脳腫瘍診断・治療市場：種類別市場規模予測 2021年-2026年（原発性脳腫瘍、続発性脳腫瘍） ・世界の脳腫瘍診断・治療市場：用途別市場規模 2015年-2020年（病院、医療センター） ・世界の脳腫瘍診断・治療市場：用途別市場規模予測 2021年-2026年（病院、医療センター） ・北米の脳腫瘍診断・治療市場分析：米国、カナダ ・ヨーロッパの脳腫瘍診断・治療市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの脳腫瘍診断・治療市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の脳腫瘍診断・治療市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの脳腫瘍診断・治療市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：AstraZeneca、Carestream Health、GE Healthcare、Hitachi、Merck、Philips Healthcare、Pfizer、Shimadzu、Siemens Healthineers、Canon Medical Systems ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
With the increasing prevalence of brain cancer, rising aging population, and growing incidences of cancer via chemical exposure, the demand of Diagnosis and treatment of brain tumors is increasing.
Market Analysis and Insights: Global Brain Tumor Diagnosis and Treatments Market
The global Brain Tumor Diagnosis and Treatments market size is projected to reach US$ 444.8 million by 2026, from US$ 422.8 million in 2020, at a CAGR of 4.8%% during 2021-2026.
Global Brain Tumor Diagnosis and Treatments Scope and Market Size
Brain Tumor Diagnosis and Treatments market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Brain Tumor Diagnosis and Treatments market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
AstraZeneca
Carestream Health
GE Healthcare
Hitachi
Merck
Philips Healthcare
Pfizer
Shimadzu
Siemens Healthineers
Canon Medical Systems
Market segment by Type, the product can be split into
Primary Brain Tumor
Secondary Brain Tumor
Market segment by Application, split into
Hospital
Medical center
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Brain Tumor Diagnosis and Treatments Revenue
1.4 Market by Type
1.4.1 Global Brain Tumor Diagnosis and Treatments Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Primary Brain Tumor
1.4.3 Secondary Brain Tumor
1.5 Market by Application
1.5.1 Global Brain Tumor Diagnosis and Treatments Market Share by Application: 2020 VS 2026
1.5.2 Hospital
1.5.3 Medical center
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Brain Tumor Diagnosis and Treatments Market Perspective (2015-2026)
2.2 Global Brain Tumor Diagnosis and Treatments Growth Trends by Regions
2.2.1 Brain Tumor Diagnosis and Treatments Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Brain Tumor Diagnosis and Treatments Historic Market Share by Regions (2015-2020)
2.2.3 Brain Tumor Diagnosis and Treatments Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Brain Tumor Diagnosis and Treatments Market Growth Strategy
2.3.6 Primary Interviews with Key Brain Tumor Diagnosis and Treatments Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Brain Tumor Diagnosis and Treatments Players by Market Size
3.1.1 Global Top Brain Tumor Diagnosis and Treatments Players by Revenue (2015-2020)
3.1.2 Global Brain Tumor Diagnosis and Treatments Revenue Market Share by Players (2015-2020)
3.1.3 Global Brain Tumor Diagnosis and Treatments Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Brain Tumor Diagnosis and Treatments Market Concentration Ratio
3.2.1 Global Brain Tumor Diagnosis and Treatments Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Brain Tumor Diagnosis and Treatments Revenue in 2019
3.3 Brain Tumor Diagnosis and Treatments Key Players Head office and Area Served
3.4 Key Players Brain Tumor Diagnosis and Treatments Product Solution and Service
3.5 Date of Enter into Brain Tumor Diagnosis and Treatments Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Brain Tumor Diagnosis and Treatments Historic Market Size by Type (2015-2020)
4.2 Global Brain Tumor Diagnosis and Treatments Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Brain Tumor Diagnosis and Treatments Market Size by Application (2015-2020)
5.2 Global Brain Tumor Diagnosis and Treatments Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Brain Tumor Diagnosis and Treatments Market Size (2015-2020)
6.2 Brain Tumor Diagnosis and Treatments Key Players in North America (2019-2020)
6.3 North America Brain Tumor Diagnosis and Treatments Market Size by Type (2015-2020)
6.4 North America Brain Tumor Diagnosis and Treatments Market Size by Application (2015-2020)
7 Europe
7.1 Europe Brain Tumor Diagnosis and Treatments Market Size (2015-2020)
7.2 Brain Tumor Diagnosis and Treatments Key Players in Europe (2019-2020)
7.3 Europe Brain Tumor Diagnosis and Treatments Market Size by Type (2015-2020)
7.4 Europe Brain Tumor Diagnosis and Treatments Market Size by Application (2015-2020)
8 China
8.1 China Brain Tumor Diagnosis and Treatments Market Size (2015-2020)
8.2 Brain Tumor Diagnosis and Treatments Key Players in China (2019-2020)
8.3 China Brain Tumor Diagnosis and Treatments Market Size by Type (2015-2020)
8.4 China Brain Tumor Diagnosis and Treatments Market Size by Application (2015-2020)
9 Japan
9.1 Japan Brain Tumor Diagnosis and Treatments Market Size (2015-2020)
9.2 Brain Tumor Diagnosis and Treatments Key Players in Japan (2019-2020)
9.3 Japan Brain Tumor Diagnosis and Treatments Market Size by Type (2015-2020)
9.4 Japan Brain Tumor Diagnosis and Treatments Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Brain Tumor Diagnosis and Treatments Market Size (2015-2020)
10.2 Brain Tumor Diagnosis and Treatments Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Brain Tumor Diagnosis and Treatments Market Size by Type (2015-2020)
10.4 Southeast Asia Brain Tumor Diagnosis and Treatments Market Size by Application (2015-2020)
11 India
11.1 India Brain Tumor Diagnosis and Treatments Market Size (2015-2020)
11.2 Brain Tumor Diagnosis and Treatments Key Players in India (2019-2020)
11.3 India Brain Tumor Diagnosis and Treatments Market Size by Type (2015-2020)
11.4 India Brain Tumor Diagnosis and Treatments Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Brain Tumor Diagnosis and Treatments Market Size (2015-2020)
12.2 Brain Tumor Diagnosis and Treatments Key Players in Central & South America (2019-2020)
12.3 Central & South America Brain Tumor Diagnosis and Treatments Market Size by Type (2015-2020)
12.4 Central & South America Brain Tumor Diagnosis and Treatments Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 AstraZeneca
13.1.1 AstraZeneca Company Details
13.1.2 AstraZeneca Business Overview
13.1.3 AstraZeneca Brain Tumor Diagnosis and Treatments Introduction
13.1.4 AstraZeneca Revenue in Brain Tumor Diagnosis and Treatments Business (2015-2020))
13.1.5 AstraZeneca Recent Development
13.2 Carestream Health
13.2.1 Carestream Health Company Details
13.2.2 Carestream Health Business Overview
13.2.3 Carestream Health Brain Tumor Diagnosis and Treatments Introduction
13.2.4 Carestream Health Revenue in Brain Tumor Diagnosis and Treatments Business (2015-2020)
13.2.5 Carestream Health Recent Development
13.3 GE Healthcare
13.3.1 GE Healthcare Company Details
13.3.2 GE Healthcare Business Overview
13.3.3 GE Healthcare Brain Tumor Diagnosis and Treatments Introduction
13.3.4 GE Healthcare Revenue in Brain Tumor Diagnosis and Treatments Business (2015-2020)
13.3.5 GE Healthcare Recent Development
13.4 Hitachi
13.4.1 Hitachi Company Details
13.4.2 Hitachi Business Overview
13.4.3 Hitachi Brain Tumor Diagnosis and Treatments Introduction
13.4.4 Hitachi Revenue in Brain Tumor Diagnosis and Treatments Business (2015-2020)
13.4.5 Hitachi Recent Development
13.5 Merck
13.5.1 Merck Company Details
13.5.2 Merck Business Overview
13.5.3 Merck Brain Tumor Diagnosis and Treatments Introduction
13.5.4 Merck Revenue in Brain Tumor Diagnosis and Treatments Business (2015-2020)
13.5.5 Merck Recent Development
13.6 Philips Healthcare
13.6.1 Philips Healthcare Company Details
13.6.2 Philips Healthcare Business Overview
13.6.3 Philips Healthcare Brain Tumor Diagnosis and Treatments Introduction
13.6.4 Philips Healthcare Revenue in Brain Tumor Diagnosis and Treatments Business (2015-2020)
13.6.5 Philips Healthcare Recent Development
13.7 Pfizer
13.7.1 Pfizer Company Details
13.7.2 Pfizer Business Overview
13.7.3 Pfizer Brain Tumor Diagnosis and Treatments Introduction
13.7.4 Pfizer Revenue in Brain Tumor Diagnosis and Treatments Business (2015-2020)
13.7.5 Pfizer Recent Development
13.8 Shimadzu
13.8.1 Shimadzu Company Details
13.8.2 Shimadzu Business Overview
13.8.3 Shimadzu Brain Tumor Diagnosis and Treatments Introduction
13.8.4 Shimadzu Revenue in Brain Tumor Diagnosis and Treatments Business (2015-2020)
13.8.5 Shimadzu Recent Development
13.9 Siemens Healthineers
13.9.1 Siemens Healthineers Company Details
13.9.2 Siemens Healthineers Business Overview
13.9.3 Siemens Healthineers Brain Tumor Diagnosis and Treatments Introduction
13.9.4 Siemens Healthineers Revenue in Brain Tumor Diagnosis and Treatments Business (2015-2020)
13.9.5 Siemens Healthineers Recent Development
13.10 Canon Medical Systems
13.10.1 Canon Medical Systems Company Details
13.10.2 Canon Medical Systems Business Overview
13.10.3 Canon Medical Systems Brain Tumor Diagnosis and Treatments Introduction
13.10.4 Canon Medical Systems Revenue in Brain Tumor Diagnosis and Treatments Business (2015-2020)
13.10.5 Canon Medical Systems Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Brain Tumor Diagnosis and Treatments Key Market Segments
Table 2. Key Players Covered: Ranking by Brain Tumor Diagnosis and Treatments Revenue
Table 3. Ranking of Global Top Brain Tumor Diagnosis and Treatments Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Brain Tumor Diagnosis and Treatments Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Primary Brain Tumor
Table 6. Key Players of Secondary Brain Tumor
Table 7. Global Brain Tumor Diagnosis and Treatments Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 8. Global Brain Tumor Diagnosis and Treatments Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global Brain Tumor Diagnosis and Treatments Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global Brain Tumor Diagnosis and Treatments Market Share by Regions (2015-2020)
Table 11. Global Brain Tumor Diagnosis and Treatments Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global Brain Tumor Diagnosis and Treatments Market Share by Regions (2021-2026)
Table 13. Market Top Trends
Table 14. Key Drivers: Impact Analysis
Table 15. Key Challenges
Table 16. Brain Tumor Diagnosis and Treatments Market Growth Strategy
Table 17. Main Points Interviewed from Key Brain Tumor Diagnosis and Treatments Players
Table 18. Global Brain Tumor Diagnosis and Treatments Revenue by Players (2015-2020) (Million US$)
Table 19. Global Brain Tumor Diagnosis and Treatments Market Share by Players (2015-2020)
Table 20. Global Top Brain Tumor Diagnosis and Treatments Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Brain Tumor Diagnosis and Treatments as of 2019)
Table 21. Global Brain Tumor Diagnosis and Treatments by Players Market Concentration Ratio (CR5 and HHI)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Brain Tumor Diagnosis and Treatments Product Solution and Service
Table 24. Date of Enter into Brain Tumor Diagnosis and Treatments Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Brain Tumor Diagnosis and Treatments Market Size by Type (2015-2020) (Million US$)
Table 27. Global Brain Tumor Diagnosis and Treatments Market Size Share by Type (2015-2020)
Table 28. Global Brain Tumor Diagnosis and Treatments Revenue Market Share by Type (2021-2026)
Table 29. Global Brain Tumor Diagnosis and Treatments Market Size Share by Application (2015-2020)
Table 30. Global Brain Tumor Diagnosis and Treatments Market Size by Application (2015-2020) (Million US$)
Table 31. Global Brain Tumor Diagnosis and Treatments Market Size Share by Application (2021-2026)
Table 32. North America Key Players Brain Tumor Diagnosis and Treatments Revenue (2019-2020) (Million US$)
Table 33. North America Key Players Brain Tumor Diagnosis and Treatments Market Share (2019-2020)
Table 34. North America Brain Tumor Diagnosis and Treatments Market Size by Type (2015-2020) (Million US$)
Table 35. North America Brain Tumor Diagnosis and Treatments Market Share by Type (2015-2020)
Table 36. North America Brain Tumor Diagnosis and Treatments Market Size by Application (2015-2020) (Million US$)
Table 37. North America Brain Tumor Diagnosis and Treatments Market Share by Application (2015-2020)
Table 38. Europe Key Players Brain Tumor Diagnosis and Treatments Revenue (2019-2020) (Million US$)
Table 39. Europe Key Players Brain Tumor Diagnosis and Treatments Market Share (2019-2020)
Table 40. Europe Brain Tumor Diagnosis and Treatments Market Size by Type (2015-2020) (Million US$)
Table 41. Europe Brain Tumor Diagnosis and Treatments Market Share by Type (2015-2020)
Table 42. Europe Brain Tumor Diagnosis and Treatments Market Size by Application (2015-2020) (Million US$)
Table 43. Europe Brain Tumor Diagnosis and Treatments Market Share by Application (2015-2020)
Table 44. China Key Players Brain Tumor Diagnosis and Treatments Revenue (2019-2020) (Million US$)
Table 45. China Key Players Brain Tumor Diagnosis and Treatments Market Share (2019-2020)
Table 46. China Brain Tumor Diagnosis and Treatments Market Size by Type (2015-2020) (Million US$)
Table 47. China Brain Tumor Diagnosis and Treatments Market Share by Type (2015-2020)
Table 48. China Brain Tumor Diagnosis and Treatments Market Size by Application (2015-2020) (Million US$)
Table 49. China Brain Tumor Diagnosis and Treatments Market Share by Application (2015-2020)
Table 50. Japan Key Players Brain Tumor Diagnosis and Treatments Revenue (2019-2020) (Million US$)
Table 51. Japan Key Players Brain Tumor Diagnosis and Treatments Market Share (2019-2020)
Table 52. Japan Brain Tumor Diagnosis and Treatments Market Size by Type (2015-2020) (Million US$)
Table 53. Japan Brain Tumor Diagnosis and Treatments Market Share by Type (2015-2020)
Table 54. Japan Brain Tumor Diagnosis and Treatments Market Size by Application (2015-2020) (Million US$)
Table 55. Japan Brain Tumor Diagnosis and Treatments Market Share by Application (2015-2020)
Table 56. Southeast Asia Key Players Brain Tumor Diagnosis and Treatments Revenue (2019-2020) (Million US$)
Table 57. Southeast Asia Key Players Brain Tumor Diagnosis and Treatments Market Share (2019-2020)
Table 58. Southeast Asia Brain Tumor Diagnosis and Treatments Market Size by Type (2015-2020) (Million US$)
Table 59. Southeast Asia Brain Tumor Diagnosis and Treatments Market Share by Type (2015-2020)
Table 60. Southeast Asia Brain Tumor Diagnosis and Treatments Market Size by Application (2015-2020) (Million US$)
Table 61. Southeast Asia Brain Tumor Diagnosis and Treatments Market Share by Application (2015-2020)
Table 62. India Key Players Brain Tumor Diagnosis and Treatments Revenue (2019-2020) (Million US$)
Table 63. India Key Players Brain Tumor Diagnosis and Treatments Market Share (2019-2020)
Table 64. India Brain Tumor Diagnosis and Treatments Market Size by Type (2015-2020) (Million US$)
Table 65. India Brain Tumor Diagnosis and Treatments Market Share by Type (2015-2020)
Table 66. India Brain Tumor Diagnosis and Treatments Market Size by Application (2015-2020) (Million US$)
Table 67. India Brain Tumor Diagnosis and Treatments Market Share by Application (2015-2020)
Table 68. Central & South America Key Players Brain Tumor Diagnosis and Treatments Revenue (2019-2020) (Million US$)
Table 69. Central & South America Key Players Brain Tumor Diagnosis and Treatments Market Share (2019-2020)
Table 70. Central & South America Brain Tumor Diagnosis and Treatments Market Size by Type (2015-2020) (Million US$)
Table 71. Central & South America Brain Tumor Diagnosis and Treatments Market Share by Type (2015-2020)
Table 72. Central & South America Brain Tumor Diagnosis and Treatments Market Size by Application (2015-2020) (Million US$)
Table 73. Central & South America Brain Tumor Diagnosis and Treatments Market Share by Application (2015-2020)
Table 74. AstraZeneca Company Details
Table 75. AstraZeneca Business Overview
Table 76. AstraZeneca Product
Table 77. AstraZeneca Revenue in Brain Tumor Diagnosis and Treatments Business (2015-2020) (Million US$)
Table 78. AstraZeneca Recent Development
Table 79. Carestream Health Company Details
Table 80. Carestream Health Business Overview
Table 81. Carestream Health Product
Table 82. Carestream Health Revenue in Brain Tumor Diagnosis and Treatments Business (2015-2020) (Million US$)
Table 83. Carestream Health Recent Development
Table 84. GE Healthcare Company Details
Table 85. GE Healthcare Business Overview
Table 86. GE Healthcare Product
Table 87. GE Healthcare Revenue in Brain Tumor Diagnosis and Treatments Business (2015-2020) (Million US$)
Table 88. GE Healthcare Recent Development
Table 89. Hitachi Company Details
Table 90. Hitachi Business Overview
Table 91. Hitachi Product
Table 92. Hitachi Revenue in Brain Tumor Diagnosis and Treatments Business (2015-2020) (Million US$)
Table 93. Hitachi Recent Development
Table 94. Merck Company Details
Table 95. Merck Business Overview
Table 96. Merck Product
Table 97. Merck Revenue in Brain Tumor Diagnosis and Treatments Business (2015-2020) (Million US$)
Table 98. Merck Recent Development
Table 99. Philips Healthcare Company Details
Table 100. Philips Healthcare Business Overview
Table 101. Philips Healthcare Product
Table 102. Philips Healthcare Revenue in Brain Tumor Diagnosis and Treatments Business (2015-2020) (Million US$)
Table 103. Philips Healthcare Recent Development
Table 104. Pfizer Company Details
Table 105. Pfizer Business Overview
Table 106. Pfizer Product
Table 107. Pfizer Revenue in Brain Tumor Diagnosis and Treatments Business (2015-2020) (Million US$)
Table 108. Pfizer Recent Development
Table 109. Shimadzu Business Overview
Table 110. Shimadzu Product
Table 111. Shimadzu Company Details
Table 112. Shimadzu Revenue in Brain Tumor Diagnosis and Treatments Business (2015-2020) (Million US$)
Table 113. Shimadzu Recent Development
Table 114. Siemens Healthineers Company Details
Table 115. Siemens Healthineers Business Overview
Table 116. Siemens Healthineers Product
Table 117. Siemens Healthineers Revenue in Brain Tumor Diagnosis and Treatments Business (2015-2020) (Million US$)
Table 118. Siemens Healthineers Recent Development
Table 119. Canon Medical Systems Company Details
Table 120. Canon Medical Systems Business Overview
Table 121. Canon Medical Systems Product
Table 122. Canon Medical Systems Revenue in Brain Tumor Diagnosis and Treatments Business (2015-2020) (Million US$)
Table 123. Canon Medical Systems Recent Development
Table 124. Research Programs/Design for This Report
Table 125. Key Data Information from Secondary Sources
Table 126. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Brain Tumor Diagnosis and Treatments Market Share by Type: 2020 VS 2026
Figure 2. Primary Brain Tumor Features
Figure 3. Secondary Brain Tumor Features
Figure 4. Global Brain Tumor Diagnosis and Treatments Market Share by Application: 2020 VS 2026
Figure 5. Hospital Case Studies
Figure 6. Medical center Case Studies
Figure 7. Brain Tumor Diagnosis and Treatments Report Years Considered
Figure 8. Global Brain Tumor Diagnosis and Treatments Market Size YoY Growth 2015-2026 (US$ Million)
Figure 9. Global Brain Tumor Diagnosis and Treatments Market Share by Regions: 2020 VS 2026
Figure 10. Global Brain Tumor Diagnosis and Treatments Market Share by Regions (2021-2026)
Figure 11. Porter's Five Forces Analysis
Figure 12. Global Brain Tumor Diagnosis and Treatments Market Share by Players in 2019
Figure 13. Global Top Brain Tumor Diagnosis and Treatments Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Brain Tumor Diagnosis and Treatments as of 2019
Figure 14. The Top 10 and 5 Players Market Share by Brain Tumor Diagnosis and Treatments Revenue in 2019
Figure 15. North America Brain Tumor Diagnosis and Treatments Market Size YoY Growth (2015-2020) (Million US$)
Figure 16. Europe Brain Tumor Diagnosis and Treatments Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. China Brain Tumor Diagnosis and Treatments Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Japan Brain Tumor Diagnosis and Treatments Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Southeast Asia Brain Tumor Diagnosis and Treatments Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. India Brain Tumor Diagnosis and Treatments Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Central & South America Brain Tumor Diagnosis and Treatments Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Bottom-up and Top-down Approaches for This Report
Figure 23. Data Triangulation
Figure 24. Key Executives Interviewed
小児脳腫瘍の世界市場（～2026年） Pediatric brain tumors are masses or growths of abnormal cells that occur in a child's brain or the tissue and structures that are near it. Many different types of pediatric brain tumors exist — some are noncancerous (benign) and some are cancerous (malignant). Treatment and chance of recovery (prog…- 脳腫瘍治療薬の世界市場（～2026年） A brain tumor occurs when abnormal cells form within the brain. North America dominates the brain tumor therapeutics market due to increasing technological advancements and the rising incidences of brain cancer in the country. Asia-Pacific is also expected to propel the brain tumor therapeutics mark…
- 脳腫瘍治療の世界市場（～2026年） Treatment for brain tumors depends on a number of factors including the type, location and size of the tumor as well as the patient's age and general health. Various treatments for curing brain tumor are surgery, radiation therapy, and chemotherapy, immunotherapy and so on which reduce the symptoms …
- 脳深部刺激療法（DBS）の世界市場（～2026年） Deep brain stimulation (DBS) is a neurosurgical procedure involving the implantation of a medical device called a neurostimulator (sometimes referred to as a 'brain pacemaker'), which sends electrical impulses, through implanted electrodes, to specific targets in the brain (brain nuclei) for the tre…
- 脳疾患の世界市場（～2026年） Brain diseases a part of central nervous system diseases, is a condition where the brain structure or functions alter. The brain diseases include conditions or disabilities that affect the brain. Mostly brain disorders occur due to traumatic injury, genetic or other diseases, while a small number of…